Papadopoulos NG, Szefler SJ, Bacharier LB, Maspero JF, et al. Assessment of dupilumab in children with moderate-to-severe type 2 asthma with or without evidence of allergic asthma. Allergy 2023 Apr 14. doi: 10.1111/all.15743.
PMID: 37059696